• Better life with AmoyDx
    more
  • Better life with AmoyDx
    more
  • AmoyDx won the Second Prize of National Scientific and Technological Progress Award
    more
  • Better life with AmoyDx
    more
Scroll

ABOUT AMOYDX

Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits including but not limited to EGFR, RAS, ALK, BRAF, PIK3CA and ROS1 testing kits, which were firstly approved by CFDA and CE certified. 

more
Better Life with AmoyDx

Latest News

Latest News more
19 /Feb

AmoyDx Collaborates with AstraZeneca to Co-develop HRD Companion Diagnostics for Ovarian Cancer

Xiamen, China, 19th February, 2021 – Recently Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) announced that it signed an agreement with AstraZeneca to develop a Homologous Recombination Deficiency (HRD) Companion Diagnostic (CDx) in ovarian cancer.

01 /Feb

AmoyDx at WCLC 2020 wrap-up

As a supporter to WCLC 2020, AmoyDx set up a virtual booth with NSCLC product pipeline and sponsored an Industry Symposium with the hot topics of Biomarker Panel testing in Lung Cancer. Prof. Tony Mok (Chairmen), Prof. Koichi Goto and Prof. Caicun Zhou pr

23 /Dec

AmoyDx Collaborates with Merck KGaA, Darmstadt, Germany to Develop Companion Diagnostics for China Market

Xiamen, China, December 23, 2020 (12:30 pm) – Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) announced that it signed an agreement with Merck KGaA, Darmstadt, Germany, to develop a Companion Diagnostic (CDx) test supporting the novel MET inhibitor tepo

16 /Nov

AmoyDx Signs Memorandum with AstraZeneca to Cooperate in Molecular Diagnostics in Gynecological Oncology worldwide

Xiamen, China, 16th November, 2020 – Recently Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) signed a collaborative memorandum with AstraZeneca in the third China International Import Expo.

more

New Products

new product release

    New Products

    new product release
    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR Pan Lung Cancer PCR Panel
      02
    • NGS HRD Focus Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR Pan Lung Cancer PCR Panel
      02
    • NGS HRD Focus Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR Pan Lung Cancer PCR Panel
      02
    • NGS HRD Focus Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR Pan Lung Cancer PCR Panel
      02
    • NGS HRD Focus Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
  1. NGS
  2. PCR
  3. FISH
  4. Extraction

World Conference on Lung Cancer 2020

https://wclc2020.iaslc.org/

January 26 – 29, 2021
meet us

AMP Annual(Association for Molecular Pathology) 2020

https://amp20.amp.org/

November 19-21, 2020
  • Stock Info

    Stock info
  • 81.700 +1.7 +2.13%
    Stock code:300685 2021-02-24 16:27:00 Real-time data
  • View details
Inquiry
* Required information
Manage your account info
Change your password